Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Pathway for Alzheimer's Disease in China (CPAD): A 8-week Multi-center Registry Study to Investigate AD Diagnostic Pattern in Chinese Local Real Clinical Practice

NCT01779310 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT01779310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01779310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Pathway for Alzheimer's Disease in China (CPAD): A 8-week Multi-center Registry Study to Investigate AD Diagnostic Pattern in Chinese Local Real Clinical Practice
Lead sponsor
Peking University
Phase
Observational
Overall status
Completed
Start date
November 30, 2012
Completion date
April 30, 2013
Enrollment
1,024 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, dementia, mild cognitive impairment